AG Derek Schmidt Announces Settlement With Pfizer For Deceptive Advertising In Drug Copay Card Program

TOPEKA – (May 25, 2022) – A biopharmaceutical company has been ordered to pay more than $85,000 in restitution to Kansas consumers following an investigation into the company’s business and advertising practices involving its copayment coupon program, Attorney General Derek Schmidt said today.

The settlement resolves allegations that Pfizer, Inc., deceptively marketed its copayment coupon program for its Estring, Quillivant XR and Quillichew ER (“Quillivant”), and Flector Patch products. Pfizer distributed coupons promising consumers would pay “no more than $15 or $20,” for example, for prescriptions without clearly and conspicuously disclosing the material terms and conditions as required by the Kansas Consumer Protection Act.

The company’s copayment coupons stated in large, clear text that eligible consumers would “PAY NO MORE THAN” certain amounts out-of-pocket. In fact, consumers frequently paid significantly more because of limits on total savings that were not prominently disclosed.

Schmidt’s office opened an investigation into Pfizer’s marketing of its copayment coupons to Kansas consumers following the receipt of information that consumers obtained a deceptive Estring copayment coupon. The coupon included the deceptive language “PAY NO MORE THAN $15.” The company has since changed the text of the Estring, Quillivant, and Flector Patch copayment coupons to explain that patients could “pay as little as” a listed amount.

Read the full story here.